These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 20160362

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
    Zelefsky MJ, Kollmeier M, Cox B, Fidaleo A, Sperling D, Pei X, Carver B, Coleman J, Lovelock M, Hunt M.
    Int J Radiat Oncol Biol Phys; 2012 Sep 01; 84(1):125-9. PubMed ID: 22330997
    [Abstract] [Full Text] [Related]

  • 3. Application of dose compensation in image-guided radiotherapy of prostate cancer.
    Wu Q, Liang J, Yan D.
    Phys Med Biol; 2006 Mar 21; 51(6):1405-19. PubMed ID: 16510952
    [Abstract] [Full Text] [Related]

  • 4. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D, Martinez A, Yan D, Lockman D, Wallace M, Gustafson G, Chen P, Vicini F, Wong J.
    Int J Radiat Oncol Biol Phys; 2005 Feb 01; 61(2):400-8. PubMed ID: 15667959
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S, Saracino B, Petrongari MG, Gomellini S, Marzi S, Landoni V, Gallucci M, Sperduti I, Arcangeli G.
    Radiother Oncol; 2007 Aug 01; 84(2):148-55. PubMed ID: 17692416
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Benefit of intensity modulated and image-guided radiotherapy in prostate cancer].
    Latorzeff I, Mazurier J, Boutry C, Dudouet P, Richaud P, de Crevoisier R.
    Cancer Radiother; 2010 Oct 01; 14(6-7):479-87. PubMed ID: 20797889
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Dosimetric evaluation of intensity-modulated tangential beam versus conventional tangential irradiation for breast cancer].
    Huang XB, Jiang GL, Chen JY, Chen LF, Hu WG.
    Ai Zheng; 2006 Jul 01; 25(7):855-60. PubMed ID: 16831277
    [Abstract] [Full Text] [Related]

  • 18. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
    Mock U, Bogner J, Georg D, Auberger T, Pötter R.
    Strahlenther Onkol; 2005 Jul 01; 181(7):448-55. PubMed ID: 15995838
    [Abstract] [Full Text] [Related]

  • 19. Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma.
    Martin JM, Rosewall T, Bayley A, Bristow R, Chung P, Crook J, Gospodarowicz M, McLean M, Ménard C, Milosevic M, Warde P, Catton C.
    Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1084-9. PubMed ID: 17606331
    [Abstract] [Full Text] [Related]

  • 20. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
    Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK.
    Cancer; 2009 Dec 01; 115(23):5596-606. PubMed ID: 19670452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.